<- Go Home
FibroBiologics, Inc.
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Market Cap
$17.5M
Volume
325.9K
Cash and Equivalents
$4.9M
EBITDA
-$17.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$2.98
52 Week Low
$0.28
Dividend
N/A
Price / Book Value
131.32
Price / Earnings
-0.70
Price / Tangible Book Value
131.32
Enterprise Value
$19.7M
Enterprise Value / EBITDA
-1.18
Operating Income
-$17.8M
Return on Equity
1292.87%
Return on Assets
-115.62
Cash and Short Term Investments
$4.9M
Debt
$7.1M
Equity
$125.0K
Revenue
N/A
Unlevered FCF
-$12.9M
Sector
Biotechnology
Category
N/A